- Home
- MGY vs VKTX Comparison
MGY vs VKTX Comparison
Compare MGY & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGY
- VKTX
- Stock Information
- Founded
- MGY 2017
- VKTX 2012
- Country
- MGY United States
- VKTX United States
- Employees
- MGY N/A
- VKTX N/A
- Industry
- MGY Oil & Gas Production
- VKTX Biotechnology: Pharmaceutical Preparations
- Sector
- MGY Energy
- VKTX Health Care
- Exchange
- MGY Nasdaq
- VKTX Nasdaq
- Market Cap
- MGY 4.8B
- VKTX 4.7B
- IPO Year
- MGY 2017
- VKTX 2015
- Fundamental
- Price
- MGY $26.25
- VKTX $32.87
- Analyst Decision
- MGY Hold
- VKTX Strong Buy
- Analyst Count
- MGY 13
- VKTX 12
- Target Price
- MGY $26.36
- VKTX $106.75
- AVG Volume (30 Days)
- MGY 2.1M
- VKTX 3.5M
- Earning Date
- MGY 02-18-2025
- VKTX 02-05-2025
- Dividend Yield
- MGY 1.98%
- VKTX N/A
- EPS Growth
- MGY N/A
- VKTX N/A
- EPS
- MGY 2.02
- VKTX N/A
- Revenue
- MGY $1,311,905,000.00
- VKTX N/A
- Revenue This Year
- MGY $8.56
- VKTX N/A
- Revenue Next Year
- MGY $1.35
- VKTX N/A
- P/E Ratio
- MGY $12.98
- VKTX N/A
- Revenue Growth
- MGY 4.67
- VKTX N/A
- 52 Week Low
- MGY $19.53
- VKTX $20.92
- 52 Week High
- MGY $29.02
- VKTX $99.41
- Technical
- Relative Strength Index (RSI)
- MGY 63.36
- VKTX 26.61
- Support Level
- MGY $23.63
- VKTX $32.51
- Resistance Level
- MGY $26.84
- VKTX $43.55
- Average True Range (ATR)
- MGY 0.58
- VKTX 2.15
- MACD
- MGY 0.41
- VKTX -0.41
- Stochastic Oscillator
- MGY 85.03
- VKTX 17.78
About MGY Magnolia Oil & Gas Corporation
Magnolia Oil & Gas Corp is an independent oil and natural gas company engaged in the acquisition, development, exploration, and production of oil, natural gas, and natural gas liquid (NGL) reserves. The Company's oil and natural gas properties are located in Karnes County and the Giddings area in South Texas, where the Company targets the Eagle Ford Shale and Austin Chalk formations. Its objective is to generate stock market value over the long term through consistent organic production growth, high full-cycle operating margins, and an efficient capital program with short economic paybacks. The company's operating segment is acquisition, development, exploration, and production of oil and natural gas properties located in the United States.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.